Skip to main content
. 2016 May 3;43(3):177–182. doi: 10.1159/000446217

Table 2.

Initially ID-NAT-reactive tissue donorsa

Tissue Specimen type Ultrio Elite Ultrio dHIV dHCV dHBV HIV HCV HBsAg Anti Anti-HBs Anti-HBc
donor # Elite 2 Ag/Ab Ab HBc IU/l IgM
4 plasma + (1:5) ND ND ND + (1:10)** + 32
5 serum + ND ND ND + (1:4) + 181
6 plasma (cadaveric) + ND + + +
7 serum +(1:2) ND ND ND ND + + ND
8 plasma (cadaveric) + + ND ND – (1:3) + 124
9 plasma + ND – (1:2) +
10 serum (cadaveric) + (serum) +*** + + ND ND
11 plasma (cadaveric) + ND ND + (1:4) ND ND +* ND ND ND ND
12 plasma +(1:3) –(1:3) ND ND ND ND ND
*

Also positive for HCV antigen.

**

1:10 dilution not validated.

***

Additional plasma sample tested.

a

Several specimens had to be diluted prior to testing due to insufficient volume, dilution factors are indicated in brackets. In donor #11, serological screening was performed in another laboratory, merely HCV serology and ID-NAT was requested.

dHIV, dHCV and dHBV = Discriminatory tests for HIV-1/2, HCV and HBV, respectively (tests provided with the Ultrio Elite Kit); ND = not done.